Belka C - Search Results

1

Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: A multicenter DKTK/ROG analysis.

Niyazi M, Adeberg S, Kaul D, Boulesteix AL, Bougatf N, Fleischmann DF, Grün A, Krämer A, Rödel C, Eckert F, Paulsen F, Kessel KA, Combs SE, Oehlke O, Grosu AL, Seidlitz A, Lattermann A, Krause M, Baumann M, Guberina M, Stuschke M, Budach V, Belka C, Debus J. Niyazi M, et al. Among authors: belka c. Radiother Oncol. 2018 Apr;127(1):121-127. doi: 10.1016/j.radonc.2018.01.011. Epub 2018 Feb 9. Radiother Oncol. 2018. PMID: 29433917

2

[The use of sucralfate in radiation oncology].

Belka C, Hoffmann W, Paulsen F, Barnberg M. Belka C, et al. Strahlenther Onkol. 1997 May;173(5):247-52. doi: 10.1007/BF03039433. Strahlenther Onkol. 1997. PMID: 9198905 Review. German.

3

Chemotherapy in the treatment of recurrent glioblastoma multiforme: ifosfamide versus temozolomide.

Paulsen F, Hoffmann W, Becker G, Belka C, Weinmann M, Classen J, Kortmann RD, Bamberg M. Paulsen F, et al. Among authors: belka c. J Cancer Res Clin Oncol. 1999 Jul;125(7):411-8. doi: 10.1007/s004320050295. J Cancer Res Clin Oncol. 1999. PMID: 10394962 Clinical Trial.

4

Cystosarcoma phyllodes malignum: a case report of a successive triple modality treatment.

Paulsen F, Belka C, Gromoll C, Hehr T, Friedel G, Wolf H, Budach W, Bamberg M. Paulsen F, et al. Among authors: belka c. Int J Hyperthermia. 2000 Jul-Aug;16(4):319-24. doi: 10.1080/02656730050074087. Int J Hyperthermia. 2000. PMID: 10949128 Free article.

5

Molecular requirements for the combined effects of TRAIL and ionising radiation.

Marini P, Jendrossek V, Durand E, Gruber C, Budach W, Belka C. Marini P, et al. Among authors: belka c. Radiother Oncol. 2003 Aug;68(2):189-98. doi: 10.1016/s0167-8140(03)00186-5. Radiother Oncol. 2003. PMID: 12972315

6

70 Gy or more: which dose for which prostate cancer?

Ganswindt U, Paulsen F, Anastasiadis AG, Stenzl A, Bamberg M, Belka C. Ganswindt U, et al. Among authors: belka c. J Cancer Res Clin Oncol. 2005 Jul;131(7):407-19. doi: 10.1007/s00432-005-0681-0. Epub 2005 May 11. J Cancer Res Clin Oncol. 2005. PMID: 15887028 Review.

7

Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition.

Ganswindt U, Paulsen F, Corvin S, Eichhorn K, Glocker S, Hundt I, Birkner M, Alber M, Anastasiadis A, Stenzl A, Bares R, Budach W, Bamberg M, Belka C. Ganswindt U, et al. Among authors: belka c. BMC Cancer. 2005 Jul 28;5:91. doi: 10.1186/1471-2407-5-91. BMC Cancer. 2005. PMID: 16048656 Free PMC article.

8

Treatment-outcome for synchronous head-and-neck and oesophageal squamous cell carcinoma.

Welz S, Schmid A, Hehr T, Schulze K, Feldmann HJ, Budach W, Bamberg M, Belka C. Welz S, et al. Among authors: belka c. Radiother Oncol. 2005 Dec;77(3):267-70. doi: 10.1016/j.radonc.2005.07.004. Epub 2005 Sep 9. Radiother Oncol. 2005. PMID: 16154220

9

Increased cytotoxicity of ionizing radiation in combination with membrane-targeted apoptosis modulators involves downregulation of protein kinase B/Akt-mediated survival-signaling.

Handrick R, Rübel A, Faltin H, Eibl H, Belka C, Jendrossek V. Handrick R, et al. Among authors: belka c. Radiother Oncol. 2006 Aug;80(2):199-206. doi: 10.1016/j.radonc.2006.07.021. Epub 2006 Aug 17. Radiother Oncol. 2006. PMID: 16916558

10

Isobologram analysis of triple therapies.

Niyazi M, Belka C. Niyazi M, et al. Among authors: belka c. Radiat Oncol. 2006 Oct 17;1:39. doi: 10.1186/1748-717X-1-39. Radiat Oncol. 2006. PMID: 17044920 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

636 results

Search Page